Literature DB >> 8612585

Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations.

T Léveillard1, L Andera, N Bissonnette, L Schaeffer, L Bracco, J M Egly, B Wasylyk.   

Abstract

The p53 tumour suppressor is mutated in the majority of human tumours. p53's proposed role as the guardian of the genome is reflected in its multiple effects on transcription genome stability, cell growth and survival. We show that p53 interacts both physically and functionally with the TFIIH complex. There are multiple protein-protein contacts, involving two regions of p53 and three subunits of TFIIH, ERCC2 (XPD), ERCC3 (XPB) and p62. p53 and its C-terminus (amino acids 320-393) inhibit both of the TFIIH helicases and in vitro transcription in the absence of TFIIH. Transcription inhibition is overcome by TFIIH. The N-terminal region of p53 (1-320), lacking the C-terminus, is inactive on its own, yet apparently affects the activity of the C-terminus in the native protein. Interestingly, mutant p53s that are frequently found in tumours are less efficient inhibitors of the helicases and transcription. We hypothesize that the interactions provide an immediate and direct link for p53 to the multiple functions of TFIIH in transcription, DNA repair and possibly the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612585      PMCID: PMC450071     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  93 in total

1.  A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.

Authors:  H W Stürzbecher; R Brain; C Addison; K Rudge; M Remm; M Grimaldi; E Keenan; J R Jenkins
Journal:  Oncogene       Date:  1992-08       Impact factor: 9.867

2.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

3.  Regulation of the specific DNA binding function of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

4.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

5.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

6.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

Authors:  P Shaw; R Bovey; S Tardy; R Sahli; B Sordat; J Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Cloning of the 62-kilodalton component of basic transcription factor BTF2.

Authors:  L Fischer; M Gerard; C Chalut; Y Lutz; S Humbert; M Kanno; P Chambon; J M Egly
Journal:  Science       Date:  1992-09-04       Impact factor: 47.728

8.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 9.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

10.  Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II.

Authors:  H Lu; L Zawel; L Fisher; J M Egly; D Reinberg
Journal:  Nature       Date:  1992-08-20       Impact factor: 49.962

View more
  38 in total

1.  An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes.

Authors:  A L Okorokov; J Milner
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

3.  p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage.

Authors:  Carlos P Rubbi; Jo Milner
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

4.  The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation.

Authors:  Gan Wang; Lynn Chuang; Xiaohong Zhang; Stephanie Colton; Alan Dombkowski; John Reiners; Amy Diakiw; Xiaoxin Susan Xu
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

5.  The contribution of transactivation subdomains 1 and 2 to p53-induced gene expression is heterogeneous but not subdomain-specific.

Authors:  Jennifer M Smith; Lawton J Stubbert; Jeffrey D Hamill; Bruce C McKay
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

Review 6.  Other proteins interacting with XP proteins.

Authors:  Steven M Shell; Yue Zou
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 7.  DNA repair pathways and their roles in drug resistance for lung adenocarcinoma.

Authors:  Altan Kara; Aykut Özgür; Sinem Nalbantoğlu; Abdullah Karadağ
Journal:  Mol Biol Rep       Date:  2021-04-15       Impact factor: 2.316

8.  p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.

Authors:  K C Lee; A J Crowe; M C Barton
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

9.  Adenovirus type 12-induced fragility of the human RNU2 locus requires p53 function.

Authors:  Z Li; A Yu; A M Weiner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

10.  Lethal mutagenesis of HIV with mutagenic nucleoside analogs.

Authors:  L A Loeb; J M Essigmann; F Kazazi; J Zhang; K D Rose; J I Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.